ePrivacy and GPDR Cookie Consent by TermsFeed Generator

MYOCET LIPOSOMAL

50MG INF PSD LQC DIS 2XSET

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Interruption of marketing 01.07.2022 0027432
Lék obtížně nahraditelný (dle uvážení lékaře)
Procedural/regulatory reasons 31.10.2022
Resumption of marketing 03.12.2018
Interruption of marketing 01.12.2018 Nahraditelný pegylovaným lipozomálním doxorubicinem (Caelyx) Capacity/distribution reasons 2019
Resumption of marketing 15.04.2018
Interruption of marketing 20.07.2017 Lék se stejnými indikacemi
Resumption of marketing 20.04.2012
Interruption of marketing 27.02.2012 lék se stejnými indikacemi
Resumption of marketing 24.02.2012

All reports are available in the Overview.

Back to list